First-in-Human Study of RLY-2608 in Advanced Breast Cancer and Other Solid Tumors.

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-500264-35-00

Acronym

RLY-2608-101

Enrollment

254

Registered

2022-08-19

Start date

2022-10-28

Completion date

Unknown

Last updated

2025-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced solid tumor with a PIK3CA mutation in blood and/or tumor per local assessment.

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Italy, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026